Skip to main content
Michael Birrer, MD, Oncology, Little Rock, AR, UAMS Medical Center

MichaelJamesBirrerMDPh.D.

Oncology • Little Rock, AR

Professor, Department of Medicine Harvard Medical School Director Gynecologic Medical Oncology

Join to view full profile

Dr. Birrer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Birrer's full profile

Already have an account?

  • Office

    UAMS Medical Center
    449 Jack Stephens Drive Winthrop P. Rockefeller Cancer Institute, Second Floor
    Little Rock, AR 72205
    Phone+1 501-686-8522
  • Is this information wrong?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1988
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1982 - 1985
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1982

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1900 - Present
  • AR State Medical License
    AR State Medical License 2019 - 2026
  • MA State Medical License
    MA State Medical License 1984 - 2019
  • AL State Medical License
    AL State Medical License 2017 - 2019
  • MD State Medical License
    MD State Medical License 1985 - 2010
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Boston Magazine Castle Connolly, 2010-2013
  • America's Top Doctors for Cancer Castle Connolly, 2010-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase Ib Study of Mirvetuximab Soravtansine, a Folate Receptor Alpha (FRα)-Targeting Antibody-Drug Conjugate (ADC), in Combination with Bevacizumab in Patients with Pl...  
    David M O'Malley, Ursula A Matulonis, Michael J Birrer, Cesar M Castro, Lainie P Martin, Kathleen N Moore, Gynecologic Oncology
  • Phase II Evaluation of Nivolumab in the Treatment of Persistent or Recurrent Cervical Cancer (NCT02257528/NRG-GY002)  
    Alessandro D Santin, Michael Frumovitz, Natalia Buza, Samir Khleif, Elena S Ratner, Roisin E O'Cearbhaill, Michael Birrer, Gynecologic Oncology
  • Primordial Germ Cells as a Potential Shared Cell of Origin for Mucinous Cystic Neoplasms of the Pancreas and Mucinous Ovarian Tumors  
    Leona A Doyle, Daniel W Cramer, Michael Goggins, Ronny Drapkin, Jason L Hornick, Kevin M Elias, Michael Birrer, Michelle S Hirsch, The Journal of Pathology
  • Join now to see all

Other

Press Mentions

  • Arkansas to Send Reserve Funds to UAMS for Cancer Center, Redirect Medical Marijuana Tax
    Arkansas to Send Reserve Funds to UAMS for Cancer Center, Redirect Medical Marijuana TaxApril 13th, 2023
  • UAMS Progressing Toward NCI Designation, Trustees Told
    UAMS Progressing Toward NCI Designation, Trustees ToldMarch 16th, 2023
  • Medical Marijuana Sales Could Bring Another Record-Breaking Year to Arkansas
    Medical Marijuana Sales Could Bring Another Record-Breaking Year to ArkansasMarch 16th, 2023
  • Join now to see all

Grant Support

  • Novel Biomarkers In Ovarian CancerNational Cancer Institute2010–2012
  • Proteomic, Genetic &Longitudinal Pathways To Ovarian Cancer Biomarker DiscoveryNational Cancer Institute2010–2011
  • Genomic Stratification Of Ovarian Cancer PatientsNational Cancer Institute2010
  • The Use Of Transcriptional Factors As Targets And Agents In CarcinogenesisDivision Of Clinical Sciences - Nci2009
  • The Molecular Genetics Of Gynecologic CancersDivision Of Clinical Sciences - Nci2009
  • The Use Of Transcriptional Factors As Targets And Agents In CarcinogenesisNational Cancer Institute2007–2008
  • The Molecular Genetics Of Gynecologic CancersNational Cancer Institute2007–2008
  • The Use Of Transcriptional Factors As Targets And AgentsDivision Of Clinical Sciences - Nci2002–2006
  • The Molecular Mechanisms Of Oncogene ActionDivision Of Clinical Sciences - Nci1996–2006
  • The Molecular Genetics Of Gynecologic CancersDivision Of Clinical Sciences - Nci1996–2006
  • Transcriptional Factors As Targets And Agents In Carcin.Division Of Clinical Sciences - Nci2004
  • Use Of Transcriptional Factors As Targets And AgentsDivision Of Clinical Sciences - Nci2001
  • Molecular Mechanisms Of Oncogene ActionDivision Of Clinical Sciences - Nci2001
  • Molecular Genetics Of Gynecologic CancersDivision Of Clinical Sciences - Nci2001
  • The Use Of Transcriptional Factors As Targets And Agents In CarcinogenesisDivision Of Clinical Sciences - Nci1999–2000
  • Use Of Transcriptional Factors As Targets And Agents In CarcinogenesisDivision Of Clinical Sciences - Nci1997–1998
  • Transcriptional Factors As Targets And Agents For ChemopreventionDivision Of Clinical Sciences - Nci1996

Hospital Affiliations

Dr. Michael Birrer, Dr. Michael Birrer, MD, Dr. M Birrer, Dr. Michael James Birrer